Oncology

Researchers at our Institute work on a multidisciplinary frontier to define cancer diagnosis, monitoring, and treatment. Their work includes investigating drug resistance mechanisms, developing bioelectronic and CRISPR-based screening, and integrating multi-omics data for biomarker discovery and individualized therapies. Artificial intelligence and radiomics are applied to improve predictive models. The researchers also examine the tumor microenvironment, metabolic changes, and immune interactions. Additional efforts focus on how dietary interventions affect cancer patient microbiota and on optimizing pharmacogenomics for pain management, ultimately aiming for precise, patient-centered outcomes.